E-Poster presented at AACR 2020

Presenter: Nigel Beaton, PhD
A collaboration with: Cedilla Therapeutics

Video Recording of Minisymposium #21 at AACR 2021

Presenter: Nigel Beaton
A collaboration with:  AstraZeneca, ETH Zurich

Minisymposium session April 11, 3:35 PM US EDT: MS.CH01.01 – Cancer Proteomics and Screening Technologies

Abstract

E-Poster presented at AACR 2020

Presenter: Yuehan Feng, PhD
A collaboration with:  ETH Zurich

Presenter: Nigel Beaton
In collaboration with the Parker Institute for Cancer Immunotherapy (PICI)

We describe a first-of-its-kind study using multi-omics biomarker approaches to demonstrate pharmacodynamic effects and immune modulation in pancreatic cancer. Biognosys’ proprietary platform for unbiased proteomics, TrueDiscovery™, allowed the identification of pharmacodynamic markers and elucidated the mechanism of action of therapies under clinical investigation.

This webinar reveals how proteomics can help overcome the challenges of treating COVID-19 patients with oncologic comorbidities. Jean-Marie Michot, a medical oncologist at Gustave Roussy Institute and Vito Dozio, Scientific Project Manager at Biognosys, share a study that illustrates the promise of proteomics in understanding responses to new therapies such as anti-IL-6-based treatment and the impact of comorbidities on clinical outcomes.

GenomeWebinar April 27, 2021
Oncology in the Time of COVID-19: Quantitative Proteomic Analysis of Anti-IL6 Treated Patients

Poster presented at ESMO 2022

 
Authors: Mitchell P. Levesque, Nigel Beaton, Kristina Beeler, Judy Kuo, Harry Nunns, Tobias Treiber, Julia Martinez Gomez, Jakob Vowinckel, and Anna Juncker-Jensen
Presenter: Mitchell P. Levesque (University of Zurich, Switzerland)

Date: September 10

Poster 3920/16 presented at AACR 2022

Presenter: Marco Tognetti
Session: PO.CH03.01 – Proteomics, Signaling Networks, and Biomarker Discovery
Date: April 13

New: Spectronaut^® 19

Unlock Your Data's True Story

New: Spectronaut^® 19

Unlock Your Data's True Story

Learn More